Loading...
Biomarkers predictive of survival and response to immune checkpoint inhibitors (ICI) in melanoma
Immunotherapy has revolutionized the treatment of melanoma. Targeting of the immune checkpoints cytotoxic T-lymphocyte-associated protein 4 and programmed cell death protein 1 has led to improved survival in a subset of patients. Unfortunately, the use of immune checkpoint inhibitors is associated w...
Saved in:
| Published in: | Am J Clin Dermatol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6994371/ https://ncbi.nlm.nih.gov/pubmed/31602560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-019-00475-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|